Cargando…
Tumor immune response and immunotherapy in gastric cancer
Remarkable developments in immuno-oncology have changed the landscape of gastric cancer (GC) treatment. Because immunotherapy intervenes with tumor immune response rather than directly targeting tumor cells, it is important to develop a greater understanding of tumor immunity. This review paper summ...
Autores principales: | Kwak, Yoonjin, Seo, An Na, Lee, Hee Eun, Lee, Hye Seung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986974/ https://www.ncbi.nlm.nih.gov/pubmed/31674166 http://dx.doi.org/10.4132/jptm.2019.10.08 |
Ejemplares similares
-
Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry
por: Park, Yujun, et al.
Publicado: (2021) -
Biomarkers for Predicting Response to Personalized Immunotherapy in Gastric Cancer
por: Kim, Moonsik, et al.
Publicado: (2023) -
Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer
por: Hwang, Hye Jung, et al.
Publicado: (2020) -
The Clinical Implication of Cancer-Associated Microvasculature and Fibroblast in Advanced Colorectal Cancer Patients with Synchronous or Metachronous Metastases
por: Kwak, Yoonjin, et al.
Publicado: (2014) -
Prognostic significance of natural killer cell-associated markers in gastric cancer: quantitative analysis using multiplex immunohistochemistry
por: Na, Hee Young, et al.
Publicado: (2021)